Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMC Ambroise Paré is a leading private medical and surgical center located in Neuilly-sur-Seine, France, and is a key component of the Groupe Hospitalier Privé Ambroise Paré - Hartmann. The facility specializes in high-complexity care across several therapeutic areas, including oncology, cardiology, nephrology, and orthopedics, serving approximately 60,000 patients annually. It is equipped with advanced medical technologies such as robotic surgery systems and state-of-the-art imaging centers, and is recognized for its high standards of care with top certifications from the French National Authority for Health (HAS). Beyond clinical services, CMC Ambroise Paré is a prominent clinical research site, hosting numerous Phase 2 and Phase 3 trials in collaboration with global pharmaceutical companies and academic institutions, particularly in the fields of oncology and inflammatory bowel disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMC Ambroise Paré.